Specialty Pharma Journal Specialty, Precision & Technology
LOUIS and BLUFFTON, S.C., Oct. 10, 2017 /PRNewswire/ — Express Scripts Holding Company (NASDAQ: ESRX) today announced that it has reached an agreement to acquire privately-held eviCore healthcare, the industry leader in evidence-based medical benefit management services, for $3.6 billion. Combining Express Scripts’ leading pharmacy benefit management offering and eviCore’s …
Tag Archives: express scripts
October, 2017
February, 2017
-
6 February
Express Scripts Fights Back Against Irresponsible Drug Pricing
LOUIS, Feb. 6, 2017 /PRNewswire/ — Express Scripts’ (NASDAQ: ESRX) efforts to put medicine within reach for payers and patients effectively held the 2016 growth rate in prescription drug spending to just 3.8 percent – a 27 percent decrease from 2015 – according to the 21st edition of its annual …
December, 2016
-
12 December
Express Scripts Announces Enhancements to Industry Leading SafeGuardRx Programs
LOUIS, Dec. 12, 2016 /PRNewswire/ — As part of its ongoing mission to put medicine within reach, Express Scripts (NASDAQ: ESRX) today announced enhancements to its landmark SafeGuardRxSM programs focusing on hepatitis C and cancer. Beginning Jan. 1, 2017, the company’s Hepatitis Cure Value Program® will now include both Viekira …
June, 2015
-
12 June
Leading the Way for Biosimilars: Managed Care’s Lonely Road
By Kathleen P. Wolff, MBA Specialty Pharma Journal Forging a pathway of innovation is typically easier with friends and allies. But these days, in the world of biosimilars, where stakeholders are still sizing each other up, allies are scarce. At the Biosimilars 20/20 conference in Philadelphia, the consensus among key opinion …
May, 2015
-
13 May
Express Scripts Report Finds Patients Taking At Least $100,000 Worth of Prescription Drugs Nearly Tripled in 2014
In 2014, the number of US patients taking at least $100,000 worth of medication nearly tripled from the previous year, according to a new report released from Express Scripts. Express Scripts released its new report, Super Spending: U.S. Trends in High-Cost Medication Use, which examines prescription drug use among patients …
April, 2015
-
7 April
CMS Guidance on Biosimilar Reimbursement is One of Many Expected in 2015
By Kathleen P. Wolff, MBA On Mar. 30, 2015, the Centers for Medicare & Medicaid Services (CMS) issued important new guidance on biosimilar reimbursement. Not only was the guidance itself noteworthy, it comes less than a month from the decision to approve the first biosimilar in the U.S. and is …
March, 2015
-
10 March
Specialty Therapies Drive Significant Increase in US Drug Spending in 2014
Spending on specialty drugs took a record rise in the US in 2014, largely due to new expensive, yet effective, hepatitis C drugs, according to new data released today in the 2014 Express Scripts Drug Trend Report. According to the pharmacy benefit manager’s (PBM) report, new hepatitis C drugs’ high …
January, 2015
-
14 January
PBM Sees New Cancer and Cholesterol Drugs as Cost Savings Opportunity
Express Scripts, the nation’s largest pharmacy benefit manager (PBM), is looking for savings from new treatments for cancer and high cholesterol. Now that Express Scripts and CVS Health, the nation’s second largest PBM, have negotiated discounts for new hepatitis C drugs, Express Scripts’ CEO said that new cholesterol and cancer …